- Thinly traded nano cap Alexza Pharmaceuticals (NASDAQ:ALXA) inks a non-binding letter of intent with Barcelona, Spain-based Grupo Ferrer Internacional, S.A. regarding Ferrer's proposed acquisition of all outstanding shares of Alexza.
- Alexza's board is reviewing the terms of the potential transaction.
- In September, Alexza retained Guggenheim Securities to advise it on ways to enhance shareholder value.
- Previously: Alexza Pharma to explore strategic alternatives (Sept. 28, 2015)